This downloadable resource includes a proposed 2019 treatment algorithm for myeloma and a list of key ongoing or enrolling clinical trials for patients with myeloma
John M. Burke, MD, and Shaji Kumar, MD, discuss practice-changing presentations in lymphomas, CLL, and multiple myeloma from ASCO 2019.
Noopur Raje, MD: Clinical impact of latest data for idecabtagene vicleucel (bb2121) and other CAR T-cells in relapsed/refractory multiple myeloma.
Expert insights from Alessandra Tedeschi, MD, on new data for B-cell malignancy management reported at the 2019 EHA and ICML meetings
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.